Ardelyx and LPGA announce multi-year partnership
Ardelyx and the LPGA announced a multi-year partnership. The collaboration aims to reduce stigma around digestive health issues affecting many people.
Ardelyx and the LPGA announced a multi-year partnership. The collaboration aims to reduce stigma around digestive health issues affecting many people.
Gilead’s first Yeztugo DTC campaign remakes a 2000s hit to spotlight twice-yearly PrEP dosing and position the injectable option around two visits a year.
Ipsen has appointed Peter Guenter to its Board of Directors effective 28 January 2026. He fills the vacancy created by Henri Beaufour’s seat.
Novo Nordisk employees have elected new representatives to the Board of Directors. The new term starts after the AGM on 26 March 2026.
Essity names Niklas Westin Sundberg as CDIO, succeeding Carl-Magnus Månsson. He joins the Executive Management Team on April 15, 2026.
Bavarian Nordic says CEO Paul Chaplin will step down for personal reasons. He will stay through 2026 or until a successor is appointed.
The medac Group appoints Dr. Christoph Willers as CSO. He will lead research, clinical development and studies, plus pipeline and portfolio management.
Novo Nordisk will invest €432m in its Athlone, Ireland, tabletting plant to add manufacturing capacity for current and future oral GLP-1 therapies.
SynAct Pharma has named Ann Kristin Led as CFO, effective 1 March 2026. The finance executive brings experience across life sciences, pharma and med-tech.
Evinova is integrating Citeline’s Sitetrove and Trialtrove data into its AI-native Study Designer to support faster, data-driven clinical trial design.